Family Consultation to Reduce Early Hospital Readmissions among Patients with End Stage Kidney Disease A Randomized Controlled Trial

被引:8
|
作者
Jasinski, Matthew J. [1 ]
Lumley, Mark A. [1 ]
Soman, Sandeep [2 ]
Yee, Jerry [2 ]
Ketterer, Mark W. [3 ]
机构
[1] Wayne State Univ, Dept Psychol, 5057 Woodward Ave,7th Floor, Detroit, MI 48202 USA
[2] Henry Ford Hlth Syst, Henry Ford Hosp, Dept Nephrol, Detroit, MI USA
[3] Henry Ford Hlth Syst, Henry Ford Hosp, Dept Psychiat, Detroit, MI USA
关键词
Adult; Centers for Medicare and Medicaid Services (US); chronic kidney failure; Cognition; Cognitive Dysfunction; Emergency Service; Hospital; Humans; Inpatients; Kidney Failure; Chronic; Literacy; Logistic Models; Male; Medicaid; Medical Records; Medicare; Middle Aged; nephrology; Patient Discharge; Patient Readmission; Referral and Consultation; risk factors; Social Support; Telephone; United States; IMMUNOSUPPRESSANT THERAPY ADHERENCE; COGNITIVE IMPAIRMENT; SOCIAL SUPPORT; CARE; RISK; PREVALENCE; MEDICINE; IMPACT; ADULTS;
D O I
10.2215/CJN.08450817
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives The US Centers for Medicare and Medicaid Services have mandated reducing early (30-day) hospital readmissions to improve patient care and reduce costs. Patients with ESKD have elevated early readmission rates, due in part to complex medical regimens but also cognitive impairment, literacy difficulties, low social support, and mood problems. We developed a brief family consultation intervention to address these risk factors and tested whether it would reduce early readmissions. Design, setting, participants, & measurements One hundred twenty hospitalized adults with ESKD (mean age=58 years; 50% men; 86% black, 14% white) were recruited from an urban, inpatient nephrology unit. Patients were randomized to the family consultation (n=60) or treatment-as-usual control (n=60) condition. Family consultations, conducted before discharge at bedside or via telephone, educated the family about the patient's cognitive and behavioral risk factors for readmission, particularly cognitive impairment, and how to compensate for them. Blinded medical record reviews were conducted 30 days later to determine readmission status (primary outcome) and any hospital return visit (readmission, emergency department, or observation; secondary outcome). Logistic regressions tested the effects of the consultation versus control on these outcomes. Results Primary analyses were intent-to-treat. The risk of a 30-day readmission after family consultation (n=12, 20%) was 0.54 compared with treatment-as-usual controls (n=19, 32%), although this effect was not statistically significant (odds ratio, 0.54; 95% confidence interval, 0.23 to 1.24; P=0.15). A similar magnitude, nonsignificant result was observed for any 30-day hospital return visit: family consultation (n=19, 32%) versus controls (n=28, 47%; odds ratio, 0.53; 95% confidence interval, 0.25 to 1.1; P=0.09). Per protocol analyses (excluding three patients who did not receive the assigned consultation) revealed similar results. Conclusions A brief consultation with family members about the patient's cognitive and psychosocial risk factors had no significant effect on 30-day hospital readmission in patients with ESKD.
引用
收藏
页码:850 / 857
页数:8
相关论文
共 50 条
  • [31] Effect of immunonutrition on inflammatory markers among end-stage liver disease patients referred for liver transplantation: Randomized controlled trial
    Beevi, S. S. Safeena
    Pottakkat, Biju
    Mohan, Pazhanivel
    Vairappan, Balasubramaniyan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 104 - 104
  • [32] EARLY DETECTION OF CHRONIC KIDNEY DISEASE AMONG RELATIVES OF END STAGE RENAL DISEASE PATIENTS: AN EPIDEMIOLOGICAL STUDY
    El-Hafeez, S. S. A.
    Gad, Z. M.
    El-Wakil, H. S.
    Hashish, M. H.
    EPIDEMIOLOGIA & PREVENZIONE, 2010, 34 (5-6): : 132 - 132
  • [33] The VITAH Trial-Vitamin D Supplementation and Cardiac Autonomic Tone in Patients with End-Stage Kidney Disease on Hemodialysis: A Blinded, Randomized Controlled Trial
    Mann, Michelle C.
    Exner, Derek V.
    Hemmelgarn, Brenda R.
    Hanley, David A.
    Turin, Tanvir C.
    MacRae, Jennifer M.
    Wheeler, David C.
    Sola, Darlene Y.
    Ramesh, Sharanya
    Ahmed, Sofia B.
    NUTRIENTS, 2016, 8 (10)
  • [34] Tissue Sodium in Patients With Early Stage Hypertension: A Randomized Controlled Trial
    Alsouqi, Aseel
    Deger, Serpil Muge
    Sahinoz, Melis
    Mambungu, Cindy
    Clagett, Adrienne R.
    Bian, Aihua
    Guide, Andrew
    Stewart, Thomas G.
    Pike, Mindy
    Robinson-Cohen, Cassianne
    Crescenzi, Rachelle
    Madhur, Meena S.
    Harrison, David G.
    Ikizler, Talat Alp
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (08):
  • [35] Can a supported self-management program for COPD upon hospital discharge reduce readmissions? A randomized controlled trial
    Johnson-Warrington, Vicki
    Rees, Karen
    Gelder, Colin
    Morgan, Mike D.
    Singh, Sally J.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 1161 - 1169
  • [36] Early referral of patients with pre-end-stage kidney disease
    Thomas, Merlin C.
    NEPHROLOGY, 2007, 12 : S41 - S43
  • [37] Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease - A randomized controlled trial
    Jamison, Rex L.
    Hartigan, Pamela
    Kaufman, James S.
    Goldfarb, David S.
    Warren, Stuart R.
    Guarino, Peter D.
    Gaziano, J. Michael
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (10): : 1163 - 1170
  • [38] THE FILTRATION IN THE NEUROPATHY OF END-STAGE KIDNEY DISEASE (FINESSE) RANDOMISED CONTROLLED TRIAL
    Kang, A.
    Arnold, R.
    Gallagher, M.
    Snelling, P.
    Green, J.
    Fernando, M.
    Kiernan, M.
    Hand, S.
    Grimley, K.
    Burman, J.
    Heath, A.
    Rogers, K.
    Bhattacharya, A.
    Smyth, B.
    Bradbury, T.
    Hawley, C.
    Perkovic, V.
    Krishnan, A. V.
    Jardine, M.
    NEPHROLOGY, 2020, 25 : 11 - 11
  • [39] Exercise in patients with hypertension and chronic kidney disease: a randomized controlled trial
    Barcellos, Franklin C.
    Del Vecchio, Fabricio Boscolo
    Reges, Annelise
    Mielke, Gregore
    Santos, Ina S.
    Umpierre, Daniel
    Bohlke, Maristela
    Hallal, Pedro C.
    JOURNAL OF HUMAN HYPERTENSION, 2018, 32 (06) : 397 - 407
  • [40] Exercise in patients with hypertension and chronic kidney disease: a randomized controlled trial
    Franklin C. Barcellos
    Fabricio Boscolo Del Vecchio
    Annelise Reges
    Gregore Mielke
    Iná S. Santos
    Daniel Umpierre
    Maristela Bohlke
    Pedro C. Hallal
    Journal of Human Hypertension, 2018, 32 : 397 - 407